IFN‐λ gene polymorphisms as predictive factors in chronic hepatitis C treatment‐naive patients without access to protease inhibitors

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-9071|87|10|1702-1715

ISSN： 0146-6615

Source： JOURNAL OF MEDICAL VIROLOGY, Vol.87, Iss.10, 2015-10, pp. : 1702-1715

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vitamin D‐related gene polymorphisms do not influence the outcome and serum vitamin D level in pegylated interferon/ribavirin therapy combined with protease inhibitor for patients with genotype 1b chronic hepatitis C

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 87, Iss. 11, 2015-11 ,pp. : 1904-1912

John Wiley & Sons Inc

Access to resources Recommend Favorite

Resistance Analyses of Integrase Strand Transfer Inhibitors within Phase 3 Clinical Trials of Treatment-Naive Patients

By White Kirsten L.   Raffi Francois   Miller Michael D.  

Viruses, Vol. 6, Iss. 7, 2014-07 ,pp. : 2858-2879

MDPI

Access to resources Recommend Favorite

Cyclophilin Inhibitors: An Emerging Class of Therapeutics for the Treatment of Chronic Hepatitis C Infection

By Hopkins Sam   Gallay Philippe  

Viruses, Vol. 4, Iss. 11, 2012-10 ,pp. : 2558-2577

MDPI

Access to resources Recommend Favorite

Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake

By  

HIV MEDICINE, Vol. 16, Iss. 10, 2015-11 ,pp. : 599-607

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatitis C Virus NS3/4A Protease Inhibitors: A Light at the End of the Tunnel

By Chatel-Chaix Laurent   Baril Martin   Lamarre Daniel  

Viruses, Vol. 2, Iss. 8, 2010-08 ,pp. : 1752-1765

MDPI

Access to resources Recommend Favorite